𝔖 Bobbio Scriptorium
✦   LIBER   ✦

855 The use of R-met Hu 6-CSF in combination with high and standard doses of Ifosfamide and doxorubicin in the patients with advanced soft tissue sarcoma

✍ Scribed by M. Erkisi; E. Erkurt; S. Ozbarlas; R. Burgut; F. Doran; E. Seyrek


Book ID
116167601
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
165 KB
Volume
31
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


High-dose alkylation therapy using ifosf
✍ Robin C. Stuart-Harris; Peter G. Harper; Colin A. Parsons; Stanley B. Kaye; Caro πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 463 KB

In a phase II study, 42 patients with advanced soft-tissue sarcoma were treated with ifosfamide by 24-h infusion and mesna by 4-h IV bolus, repeated every 3 weeks. Ten patients received ifosfamide 5.0 g/m2, 20 had the dosage increased to 8.0 g/m2, and 12 received 8.0 g/m2 from the outset. Mesna was

The efficacy of a combination of etoposi
✍ Zs. PΓ‘pai; Gy. Bodoky; J. SzΓ‘ntΓ³; I. Poller; P. RahΓ³ty; S. Eckhardt; I. LΓ‘ng; M. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 62 KB πŸ‘ 2 views

## BACKGROUND. Successful chemotherapy for patients with soft tissue sarcoma (STS) has been limited by a lack of active drugs. The most effective single agents are doxorubicin, dacarbazine, and, more recently, ifosfamide. Previously the most widely used combination has been CYVADIC (cyclophosphami